Jennifer Burstein, Senior VP of Finance at Loxo Oncology, Inc. (LOXO), sold 4,500 shares at $162.54 ($742K) on 2018-10-04, disclosed to the SEC on 2018-10-05.
Open-market sale of $742k LOXO by Senior VP of Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.53 | 590 | $98K | 13.2% |
| 2 | $165.53 | 590 | $98K | 13.2% |
| 3 | $167.10 | 100 | $17K | 2.3% |
| 4 | $168.97 | 560 | $95K | 12.8% |
| 5 | $168.97 | 560 | $95K | 12.8% |
| 6 | $161.22 | 539 |
| $87K |
| 11.7% |
| 7 | $161.22 | 539 | $87K | 11.7% |
| 8 | $162.54 | 311 | $51K | 6.8% |
| 9 | $162.54 | 311 | $51K | 6.8% |
| 10 | $164.25 | 200 | $33K | 4.4% |
| 11 | $165.05 | 200 | $33K | 4.4% |
| Total | $164.90 avg | 4,500 | $742K | 100% |
| Filing → |
| LOXO | SELL | 2018-09-14 | $667K | — | Filing → |
| LOXO | SELL | 2018-08-15 | $540K | — | Filing → |
| LOXO | SELL | 2018-07-11 | $281K | — | Filing → |